{"id": "1336533521612083201", "creation": 1607489397.0, "user_id": "1233901069366771712", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": ".@BioNTech_Group Vaccine Will Face Stiff Competition\n\nThe $BNTX #COVID19 #vaccine maybe be the first but the #revenue trajectory remains difficult to forecast &amp; rife with competition so more aggressive Street expectations may prove unrealistic.\n\n$MRNA $JNJ https://t.co/OST4LXCS4t", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#REVENUE"]}